does cjc-1295 ipamorelin suppress endogenous gh production How Work? What Is CJC 1295 Ipamorelin?

Molecular Identity Class Growth Hormone Releasing Peptide (GHRP) Mechanism Stimulates pituitary gland GH release Distinguishing Feature Selective GH release without affecting cortisol or prolactin Research Context Ipamorelin research has examined: GH secretion patterns: Studies show pulsatile GH release mimicking natural patterns Selectivity: Unlike earlier GHRPs, Ipamorelin shows minimal effect on cortisol and prolactin Recovery research: Some studies have examined applications in tissue repair models Ipamorelin is not FDA-approved and remains a research compound in the United States

The 25-mg/kg dose reduced these parameters by 48.8%, 30.3%, 33.4%, and 47.5%, respectively, while the 50-mg/kg dose showed more pronounced effects, reducing them by 67.9%, 58.6%, 60.4%, and 73.6%, respectively, in comparison with the TAA group (Figures 4AD)

[DOI] [PubMed] [Google Scholar] Rasmussen JB, Glennow C

doi: 10.1016/j.ijbiomac.2025.143989 127 ZhangHLiuXZhengYZhaXElsabaghMZhangYet al